Actively Recruiting

Age: 18Years - 80Years
All Genders
ID06562140

Multidimensional Examination of Physical Activity, Functional Capacity, and Health Status in Patients with Colorectal and Anal Cancer

Led by University of Pecs · Updated on 2025-01-23

300

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are examining physical activity, functional capacity, and health status in adults with colorectal and anal cancer. This study focuses on the impact of these cancers, especially on patients experiencing incontinence. It also involves adapting and validating quality of life questionnaires specific to colorectal and anal cancer, as well as a fecal incontinence severity index, to better understand patient experiences. The study is observational and does not involve any intervention. Participants include adults aged 18 to 80 years diagnosed with colorectal or anal carcinoma. Assessments include administering several questionnaires such as the EORTC QLQ-C30, EORTC QLQ-CR29, EORTC QLQ-AN27, the Global Physical Activity Questionnaire (GPAQ), and the Fecal Incontinence Severity Index (FISI) to capture various aspects of quality of life, physical activity, and symptom severity. Participants will complete questionnaires at baseline and report on their physical activity over one week. The study collects subjective data to evaluate how these cancers affect quality of life and physical function. The research is sponsored by the University of Pecs and will continue through September 2025, involving patients who meet the age and diagnosis criteria without certain neurological, musculoskeletal, psychiatric, or recent surgical exclusions.

CONDITIONS

Brief Title

Multidimensional Examination of Patients with Colorectal and Anal Cancer

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged 18 to 80 years
  • Diagnosed with colorectal or anal carcinoma
Not Eligible

You will not qualify if you...

  • Neuromuscular diseases
  • Severe congenital musculoskeletal and other disorders
  • Severe psychiatric illness or lack of cooperation
  • Underwent other surgical procedures within the past year

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 1 week

Participants complete baseline assessments including quality of life questionnaires and evaluations of physical activity and fecal incontinence severity.

1 visit (in-person)

Long-term Monitoring

Duration - Up to study completion

Participants are observed to assess physical activity, functional capacity, and health status over time without any intervention.

No scheduled visits; data collection is observational

Trial Site Locations

Total: 2 locations

1

University of Pécs

Pécs, Baranya, Hungary, 7621

Not Yet Recruiting

2

University of Pécs

Pécs, Hungary

Actively Recruiting

Loading map...

Research Team

A

Alexandra Makai, PhD

M

Márta Hock, PhD habil

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Phase 1/2a Study of the Safety, Tolerability, and Prelimin...

Castration-Resistant Prostate Cancer (CRPC)

Actively Recruiting

4 locations

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

A Phase 1/2a Study Utilizing 64Cu-LNTH-1363S (64Cu Radiolabe...

Metastatic Sarcoma

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here